New directions in the treatment of opioid withdrawal.
Srivastava AB, Mariani JJ, Levin FR.
Lancet. 2020 Jun 20;395(10241):1938-1948. doi: 10.1016/S0140-6736(20)30852-7.
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl.
Bird HE, Huhn AS, Dunn KE.
J Addict Med. 2023 Sep-Oct 01;17(5):503-508. doi: 10.1097/ADM.0000000000001185. Epub 2023 May 17.
Clinical pharmacology of opioids for pain.
Inturrisi CE.
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13. doi: 10.1097/00002508-200207001-00002.
The endogenous opioid system and clinical pain management.
Holden JE, Jeong Y, Forrest JM.
AACN Clin Issues. 2005 Jul-Sep;16(3):291-301. doi: 10.1097/00044067-200507000-00003.
Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.
Kudrich C, Hurd YL, Salsitz E, Wang AL.
Cannabis Cannabinoid Res. 2022 Oct;7(5):569-581. doi: 10.1089/can.2021.0089. Epub 2021 Oct 22.
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.
Spreen LA, Dittmar EN, Quirk KC, Smith MA.
Pharmacotherapy. 2022 May;42(5):411-427. doi: 10.1002/phar.2676. Epub 2022 Mar 25.
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids.
Weimer MB, Herring AA, Kawasaki SS, Meyer M, Kleykamp BA, Ramsey KS.
J Addict Med. 2023 Nov-Dec 01;17(6):632-639. doi: 10.1097/ADM.0000000000001202. Epub 2023 Jul 28.
The fragile state of opioid withdrawal.
Wong W.
Sci Signal. 2023 Feb 14;16(772):eadh0620. doi: 10.1126/scisignal.adh0620. Epub 2023 Feb 14.
A master regulator of opioid reward in the ventral prefrontal cortex.
Smith ACW, Ghoshal S, Centanni SW, Heyer MP, Corona A, Wills L, Andraka E, Lei Y, O'Connor RM, Caligiuri SPB, Khan S, Beaumont K, Sebra RP, Kieffer BL, Winder DG, Ishikawa M, Kenny PJ.
Science. 2024 Jun 7;384(6700):eadn0886. doi: 10.1126/science.adn0886. Epub 2024 Jun 7.
Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA.
London KS, Huo S, Murphy L, Warrick-Stone T, Goodstein D, Montesi M, Carter M, Butt S, Alexander K, Satz W, Tasillo A, Xu L, Arora M, Casey E, McKeever R, Lowenstein M, Durney P, Hart B, Perrone J.
J Addict Med. 2026 Mar-Apr 01;20(2):231-237. doi: 10.1097/ADM.0000000000001560. Epub 2025 Aug 1.
